Join
Live feed
·
PRReleasevia Quantisnow
Dogwood Therapeutics Inc. logo

Dogwood Therapeutics Announces FDA Acceptance of SP16 Investigational New Drug Application for the Treatment of Chemotherapy Induced Pain and Neuropathy

ByQuantisnow·Wall Street's wire, on your screen.
DWTX· Dogwood Therapeutics Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track DWTX (Dogwood Therapeutics Inc.) and more on Quantisnow.